Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialWilliam Greenhalf, Markus W. Büchler, Eithne Costello et al.|JNCI Journal of the National Cancer Institute|2013Cited by 333